Brad Rowe joined the organization in 2005 and is based from our Philadelphia, PA sites in Garnet Valley and Boothwyn. He joined QS Pharma, later acquired by Quotient Sciences in 2017, initially working in the lab, and eventually was head of all analytical activities from the Philadelphia site. 

In his current role, Brad helps the business unit teams discuss and scope programs with customers, and supports program operations as a technical advisor throughout the lifecycle of a program.

Brad graduated from the University of Pittsburgh at Johnstown with a BS in Chemistry and then the University of Delaware with a PhD in Analytical Chemistry.